T e s t i n g f o r m u t a t i o n s i n h e r e d i t a r y b r e a s t l o v a r i a n c a n c e r g e n e s (BRCAl/BRCAZ) i s a p p r o p r i a t e f o r a l i m i t e d g r o u p o f h i g h -r i s k i n d i v i d u a l s , s u c h a s some b r e a s t c a n c e r s u r v i v o r s . I t i s n o t k n o w n i f s u r v i v o r s o b t a i n i n f o r m a t i o n r e g a r d i n g g e n e t i c t e s t i n g o r w h e t h e r p h y s i c i a n s p l a y a r o l e i n t h e t e s t i n g d e c i s i o n p r o c e s s . O u r o b j e c t i v e s w e r e t o d e t e r m i n e i f h i g h -r i s k s u r v i v o r s s p e a k w i t h p h y s i c i a n s a n d r e l a t i v e s a b o u t BRCA g e n e t i c s , a n d t o d e t e r m i n e t h e i r k n o w l e d g e , t e s t i n g i n t e n t i o n s , and p r e f e r r e d i n f o r m a t i o n s o u r c e s . We c o n d u c t e d a p o p u l a t i o n -b a s e d c r o s s s e c t i o n a l s t u d y i n 1 / 9 9 a t Group H e a l t h C o o p e r a t i v e .
A l l 276 f e m a l e c u r r e n t e n r o l l e e s i n i t i a l l y d i a g n o s e d w i t h b r e a s t c a n c e r 5-10 y e a r s p r i o r t o 6130198 a n d 40-49 y e a r s o l d a t d i a g n o s i s w e r e m a i l e d a s u r v e y . O f 217 r e s p o nd e n t s , 8% s p o k e w i t h p h y s i c i a n s a n d 5 3 % s p o k e w i t h r e l a t i v e s . On a v e r a g e , women c o r r e c t l y r e s p o n d e d t o 2 o f 7 t r u e l f a l s e q u e s t i o n s . R e s p o n d e n t s who spoke w i t h p h y s i c i a n s h a d h i g h e r k n o w l e d g e s c o r e s t h a n t h o s e who d i d n o t ( p < . O O l ) . R e s p o n d e n t s p r ef e r r e d w r i t t e n m a t e r i a l s ( 8 0 . 6 % ) a n d d i s c u s s i o n s w i t h p h y s i c i a n s ( 7 9 . 8 % ) f o r BRCA i n f o r m a t i o n . I n summary, s
u r v i v o r s h a v e l i m i t e d BRCA k n o w l e d g e , t h o u g h t h e y a r e d i s c u s s i n g g e n e t i c s w i t h r e l a t i v e s P h y s i c i a n s c u r r e n t l y g i v e l i t t l e i n p u t r e g a r d i n g BRCA t e s t i n g , b u t s u r v i v o r s w o u l d c o n s i d e r t h e i r i n v o l v e m e n t h e l p f u l .
Visual presentations at 1998 ACMG meeting suggests insensitivity of geneticists to a common genetic disorder. M.S. ~i l l i a m d~.~. Wdliams2. 1Gundersen Lutheran Medical Center, 2La Crosse Regional Genetics Services Project, La Crosse, WI.
Red-green colorblindness (colorblindness, partial, deutran series, O m #303800) is a common X -l i e d recessive disorder affecting approximately 8% of the male population. Individuals with this disorder have diiculty perceiving the diierence between the primary colors red and green and also experience diiculty perceiving these colors against certain backgrounds. Presentations at medical meetings are very visually oriented. The new computer slide programs allow for very complex and colorful transparencies to be easily created. Comments to the authors from acquaintances with red-green colorblindness regarding their difficulty readii slides that use the colors red and green led to the current study. Thirty-six presentations at the 1998 Annual Clinical Genetics Meeting of the ACMG were attended by one or both of the authors. For each session data was obtained on three parameters: Were slides used, were the cdors red andor green used in text or figures of the slides, how many slides used red andor green to highlight information critical to the understanding of a slide. Only primary red or green were scored as a positive. Of the 36 presentations, 34 utilized slides. Of these 34 presentations 19 (56%) used red andor green In all cases (19119 100%) red andor green was used to highlight information critical to the understanding of at least one slide in these presentations. The average number of critical slides containing red or green highlighted information was 3.1 per presentation. Geneticists should be aware that use of red or green in presentations impairs information transfer to a portion of their audience.
Evaluating data from newborn screenlnq Droarams -Georgia. 1998. S.S. ~a n q ' , P.M. ~ernhoff2. K ~rinzaid'. M-kamachandran3. E.A. ~r a n k o~x enso on^, J. Buehler5, M.J. ~houry'. 'office of Genetlcs and Disease Prevention, CDC, Atlanta. GA. '~mory Univ. School of Medicine. Atlanta. GA, '~eorgia Public Health Laboratory. Atlanta, 4~eorgia Genetics Program. Atlanta, '~iv-of Public Health. GA Newborn screening (NBS) programs In the U.S. annually screen four million infants for metabolic and other disorders to prevent mental retardation. disability, and death. Assuring the effectiveness of NBS programs requires the collect~on of appropriate data for program evaluation, including short-term outcome measures (screening coverage, specimen quality, timeliness of diagnosisltreatment) and long-term outcome measures (morbidity, premature mortality, disability). We evaluated the data systems of the GA NBS program (GA NBS laboratory database and Emory University Medical Genetics database) and assessed our ability to measure these short-and potential longterm outcomes.
From January 1, 1998 to December 31, 1998, the NBS laboratory received 199,387 specimens. Of these specimens. 135.163 (67.8%) were collected in a satisfactory manner and received by the laboratory in the appropriate time frame (less than one week of age). Another 20.839 specimens (10.4%) were collected In a satisfactory manner, but obtained afler one week of age. 20.691 (10.4%) specimens were collected from low birth weight newborns and 20.687 (10.4%) specimens were classified as unsatisfactory. Of all specimens, there were 4,557 ~nitlally abnormal screening results. Final normal results were ascertained for 4.094 of these results. Clinically significant disorders were diagnosed in 93 Infants; these infants received thelr first abnormal test results within one week of age and inltial treatments between one week to two months of age.
Data unavailable from the current system include the number of children the 199.387 specimens represent. Furthermore. the current system does not allow for the assessment of long-term follow-up outcomes on the 93 children diagnosed wlth cllnlcally significant disorders These results demonstrate that whlle some short-term outcomes are measured, screening coverage and effectiveness of the NBS program in preventing disabilities andlor premature death cannot be adequately determined As with other state NBS programs, there IS an urgent need for the collection and llnkage of various sources of informat~on In order to conduct program evaluations
